# MBi Distributing Inc. – FDA Inspection, Jan 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/mbi-distributing-inc/d3660865-4b28-4b32-9b62-bcecf27d2c23
Source feed: FDA_Inspections

> FDA inspection 1037569 of MBi Distributing Inc., January 12, 2018. Classification: Official Action Indicated (OAI). 13 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1037569
- Company Name: MBi Distributing Inc.
- Inspection Date: 2018-01-12
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 13

## Related Officers

- [Investigator](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)
- [FDA Associated Person](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)

Company: https://www.keypedia.com/companies/mbi-distributing-inc/56f0ab09-e687-4221-a9b4-33f717a6dc3a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c